2051 RINGWOOD AVENUE, SAN JOSE, CA
Financial Results, Press Release
Termination of Tax Receivable Agreement with InCube Labs, LLC
Material disclosure
Rani Therapeutics Enters $42.6M Securities Purchase Agreement
Reports Second Quarter 2025 Financial Results; Provides Corporate Update
News, Securities Holder Rights or Indentures, Legal Opinion, Material Contracts
News
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Notice of Exempt Offering of Securities
Registration Statement for Securities Offered under a Shelf Registration
Definitive Information Statement
Preliminary Information Statement
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence